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OBJECTIVES The aim of the present study was to determine whether the combination of two markers that
reflect depolarization and repolarization abnormalities can predict future arrhythmic events
after acute myocardial infarction (MI).
BACKGROUND Although various noninvasive markers have been used to predict arrhythmic events after MI,
the positive predictive value of the markers remains low.
METHODS We prospectively assessed T-wave alternans (TWA) and late potentials (LP) by signal-
averaged electrocardiogram (ECG) and ejection fraction (EF) in 102 patients with successful
determination results after acute MI. The TWA was analyzed using the power-spectral
method during supine bicycle exercise testing. No antiarrhythmic drugs were used during the
follow-up period. The study end point was the documentation of ventricular arrhythmias.
RESULTS The TWA was present in 50 patients (49%), LP present in 21 patients (21%), and an EF
,40% in 28 patients (27%). During a follow-up period of 13 6 6 months, symptomatic,
sustained ventricular tachycardia or ventricular fibrillation occurred in 15 patients (15%). The
event rates were significantly higher in patients with TWA, LP, or an abnormal EF. The
sensitivity and the negative predictive value of TWA in predicting arrhythmic events were
very high (93% and 98%, respectively), whereas its positive predictive value (28%) was lower
than those for LP and EF. The highest positive predictive value (50%) was obtained when
TWA and LP were combined.
CONCLUSIONS The combined assessment of TWA and LP was associated with a high positive predictive
value for an arrhythmic event after acute MI. Therefore, it could be a useful index to identify
patients at high risk of arrhythmic events. (J Am Coll Cardiol 2000;35:722–30) © 2000 by
the American College of Cardiology
Following myocardial infarction (MI), serious ventricular
arrhythmias are the most frequent mechanisms responsible
for sudden cardiac death. Therefore, identification of pa-
tients at high risk for sudden cardiac death is very important
in clinical cardiology. At present, various noninvasive indi-
ces, such as late potentials (LP) determined by signal-
averaged electrocardiography (ECG) (1–3), left ventricular
ejection fraction (EF) (1–3), ventricular ectopy determined
by Holter monitoring (4), heart rate variability (5), and QT
dispersion (6), have been used to identify patients at risk for
the development of ventricular arrhythmias. In particular,
LP, which reflects abnormalities of depolarization, and EF
have been shown to be predictors of ventricular arrhythmic
events in patients after acute MI (1–3). However, the
predictive values of LP or EF alone in predicting future
serious ventricular arrhythmias have low positive predictive
values (17% to 29%) (1–3).
Recently, microvolt-level electrical alternans of the
T-wave (“microscopic” T-wave alternans [TWA]) has been
proposed to be a predictor of life-threatening ventricular
arrhythmias (7,8), and it is now feasible during exercise as a
noninvasive test (8,9). However, no studies have shown the
predictive assessment of TWA according to arrhythmic
events in the setting of acute MI. The TWA represents
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beat-to-beat variability in the amplitude of the T wave. It is
believed to reflect abnormalities of ventricular repolariza-
tion. We hypothesized that TWA and LP may be combined
(i.e., the combination of two noninvasive markers of repo-
larization and depolarization abnormalities) to predict fu-
ture ventricular arrhythmic events, and that the measure-
ment could be used as a useful noninvasive predictor of
high-risk patients. In the present study, we prospectively
determined the predictive values of TWA, LP, and EF
alone, and in combination in identifying patients at risk for
developing ventricular arrhythmias after acute MI.
METHODS
Patient population. We screened a total of 142 consecu-
tive patients with acute MIs who were admitted to the
coronary care unit of our institute between February 1997
and November 1998. Patients who died soon after admis-
sion were not included. The diagnosis of acute MI was
based on clinical course, serum creatine kinase activity, and
ECG findings corresponding to ST-segment elevation (i.e.,
transmural MI). All the screened patients underwent
screening coronary angiography on admission. Primary
percutaneous transluminal coronary angioplasty (PTCA)
was performed in most of the patients (98%) as the standard
of practice at our institute (10). None of the patients had
received thrombolytic therapy. The method of primary
PTCA utilized was either stent implantation (58%) or
conventional balloon angioplasty (42%). The success rate of
PTCA was 94% in this study period. Coronary bypass
surgery was performed when PTCA was done unsuccess-
fully. Therefore, most patients had undergone successful
revascularization procedures in this patient population.
Twenty-three patients were excluded from the study
because they had evidence of the following conditions at the
time of three tests:
1) atrial fibrillation,
2) frequent extrasystoles ($10 beats/min),
3) sinus bradycardia (,40 beats/min),
4) wide QRS complex including bundle branch block,
5) a severely reduced ejection fraction (,20%),
6) congestive heart failure,
7) implanted permanent pacemaker or cardiac defibrillator,
or
8) use of antiarrhythmic drugs and medicines (except beta-
blockers), which influence depolarization and repolariza-
tion.
Entry criteria were when exclusion criteria were not met,
and when the three tests would be feasible and be analyz-
able. Of 142 patients screened, 119 patients underwent the
assessment of the three indices (TWA, LP, and EF). The
signal-averaged ECG and TWA tests were sequentially
performed. The mean number of days that tests were
performed was 20 6 6 (range, 7 to 30 days) after the acute
MI.
In this study, a relatively broad range of testing days was
utilized because these tests were performed just prior to
hospital discharge. The EF by left ventriculography was
assessed within two days prior to the two noninvasive tests.
At that time, coronary angiography was also performed in
all patients to ensure patency after angioplasty. No arrhyth-
mic drugs were used before and during the tests in all
patients. Indeterminate TWA results were obtained in 17
patients due to extrasystoles (11 patients), a failure to
achieve heart rate $105 beats/min (4 patients), or other
clinical reasons (2 patients). An indeterminate signal-
averaged ECG result was obtained in one patient because of
right bundle branch block at the time of recording; patients
with wide QRS complex, including bundle branch block
before the tests, had already been excluded from the study.
This patient also had an indeterminate TWA result. These
17 patients with indeterminate results of TWA and signal-
averaged ECG were excluded from the study. Therefore,
102 patients (83 men and 19 women; mean age: 60 6 9
years) were prospectively assessed as the final study popu-
lation. Fifty patients (49%) had anterior wall infarctions, 35
(34%) had inferior wall infarctions and 17 (17%) had lateral
wall infarctions. This study included seven patients with
previous MI. None of the patients had other organic heart
disease (e.g., cardiomyopathy, myocarditis, or valvular dis-
ease).
Informed consent was obtained from all patients prior to
enrollment in the study. The Committee on Clinical Re-
search of Toho University Ohashi Hospital approved the
study protocol.
Measurements. LATE POTENTIALS. Before TWA assess-
ment, LP were analyzed using a signal-averaged ECG
system (model 1200EPX, Arrhythmia Research Technol-
ogy, Austin, Texas). The analysis is based on the quantita-
tive time-domain measurements of the filtered vector mag-
nitude of the orthogonal Frank X, Y, and Z leads. The QRS
complexes ($200 beats) were amplified, digitized, averaged,
and filtered with a high pass filter (40 Hz). Three param-
eters were assessed via a computer algorithm: 1) the filtered
QRS duration (f-QRS), 2) the root mean square voltage of
the terminal 40 ms of the filtered QRS (RMS40), and 3) the
duration of signals ,40 mV in the terminal filtered QRS
(LAS40). The LP were considered to be present when at
least two of three criteria (f-QRS .114 ms, RMS40 ,20
mV, or LAS40 .38 ms) were met (11). Patients with wide
Abbreviations and Acronyms
CI 5 confidence interval
ECG 5 electrocardiogram, electrocardiography
EF 5 ejection fraction
LP 5 late potentials
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary angioplasty
TWA 5 T-wave alternans
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QRS complex had been already excluded from the assess-
ment of the study.
T-WAVE ALTERNANS. After LP acquisition, in keeping the
same supine position as the signal-averaged ECG record-
ings, the orthogonal Frank X, Y, and Z leads and associated
vector magnitude (VM), and nine standard ECG leads
(aVR, AVL, aVF, V1 through V6) were recorded with newly
developed electrodes (Cambridge Heart, Bedford, Massa-
chusetts), which reduce electrical noise, after careful skin
preparation (12). The presence of TWA was assessed using
a CH2000 System (Cambridge Heart), which allows the
detection of microvolt electrical alternans of the T wave
using power spectral analysis (7). The spectral method of
TWA analysis using this system has been described previ-
ously (7,13).
In brief, the magnitude of TWA was determined from
power spectra by calculating the squared magnitude of the
fast Fourier transformation of beat-to-beat fluctuations in
the amplitudes of T waves from 128 consecutive beats.
Alternans voltage (Valt) and alternans ratio (Ralt) were
computed from the beat domain power spectrum. The Valt
was calculated as the square root of the difference between
the alternans peak voltage and the mean noise voltage in the
power spectrum. The Ralt was calculated as the ratio of the
squared alternans voltage and the standard deviation of the
noise voltage and reflects the uncertainty in the T-wave
Alternans measurements. Alternans are identified in the
power spectrum at a frequency of 0.5 cycles/beat. This
method selectively isolates alternans variability from other
fluctuations caused by noise and respiration. If ectopic beats
represented less than 10% of beats and the noise for the VM
was less than 1.5 mV, the data were considered to be valid
for analysis. The TWA was defined as positive if sustained
alternans (i.e., alternans with duration $1 min) occurred
with onset heart rate #110 beats/min in the Valt $1.9 mV
during exercise or 1.0 mV at rest, and a Ralt $3.0 in single
orthogonal leads or two adjacent precordial leads. The
TWA was defined as negative if the criteria for positivity
were not met while maintaining heart rate at a level $105
beats/min (14). Patients with indeterminate TWA results
were not included in the present study.
LEFT VENTRICULAR EJECTION FRACTION. Left ventricu-
lography was performed in a 30° right anterior oblique
projection with contrast medium in all patients prior to
TWA and LP assessment. The EF was assessed by the
area-length method. If patients had an EF less than 20%,
they were excluded from the present study before the TWA
and LP assessments. An abnormal EF was defined as an EF
,40%. A left ventricular aneurysm was defined as the
presence of regional paradoxical systolic wall motion.
Exercise protocol. For the TWA analysis, a graded bicycle
ergometer (8,9) was used to increase the heart rate to 110
beats/min because most patients have a patient-specific
heart rate threshold for the development of alternans be-
tween 80 and 110 beats/min (9,15). Because muscle con-
traction artifact during exercise can obscure electrical alter-
nans, the bicycle ergometry was performed in the supine
position. In addition, electrical alternans were measured in a
quiet room with copper shielding to reduce outside electrical
noise. After obtaining a resting ECG, bicycle exercise was
started and gradually increased to a workload of #15 W, to
increase heart rate slowly to approximately 110 beats/min.
Patients adjusted their pedaling rate to match a frequency
that was either 33% or 67% of the heart rate using
continuous auditory and visual feedback from the CH2000
system. Controlling the pedaling rate was important to
ensure reliable TWA assessment, because pedaling at a
frequency that was 50% of the heart rate would introduce an
artifact into the alternans power.
Follow-up and study end point. All patients were fol-
lowed as outpatients at our institute. Regular follow-up
contact was obtained by a hospital visit at every two or four
weeks. Although three patients had arrhythmic events
before hospital discharge (see Results for details), we
counted them as follow-up events because days at which
these events occurred were remote from onset of acute MI.
In these patients, the assessment of three indices was
performed just after the events. In this study protocol, 24-h
Holter ECG recordings were performed using a portable
two-channel tape recorder (Fukuda Denshi, Tokyo, Japan)
at one and six month(s) after hospital discharge (2.1 6 3.1
times/patient; range: 1 to 6). Follow-up angiography was
also performed in all patients to confirm maintenance of
patency after angioplasty at six months after the MI as the
standard of practice at our institute. The end point of the
study was the documentation of spontaneous ventricular
arrhythmias. When patients had symptomatic episodes,
such as palpitation, dizziness, syncope, and so on, we
instructed the patients and their families to come to an
emergency room of our institute as soon as possible.
Although physicians taking care of patients in the emer-
gency room were informed of our study protocol, results of
the three tests were not disclosed. Treatment of ventricular
arrhythmias was not standardized. If we failed to record
ECG during their symptoms, additional Holter ECG
recordings were performed to identify symptomatic ventric-
ular arrhythmias. No patients who enrolled in this study
received antiarrhythmic drugs except beta-blocker before
the documentation of ventricular arrhythmias.
Definition of arrhythmic events. We prospectively as-
sessed the development of spontaneous ventricular arrhyth-
mias during the follow-up period. Ventricular arrhythmias
were defined as symptomatic, sustained ventricular tachy-
cardia ($120 beats/min lasting .30 s) or ventricular fibril-
lation. In this study, hemodynamically stable and sustained
ventricular tachycardia was also included into arrhythmic
events if symptomatic. Nonsustained ventricular tachycar-
dias lasting less than 30 s were excluded from arrhythmic
events. Although sustained ventricular tachycardia or fibril-
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lation occurring during the hospitalization was counted as
follow-up events, the arrhythmias in acute phase (i.e., the
first seven days) of MI were not included into arrhythmic
events.
Statistical analysis. Data are expressed as the mean 6 SD.
Comparisons between arrhythmic events and clinical vari-
ables were evaluated by a contingency chi-square analysis.
For the analysis of the association among arrhythmic events
and TWA, LP, and an abnormal EF, and their combina-
tion, univariate and multivariate Cox regression analyses
were performed. Results of event-free analyses are presented
with the relative hazard and 95% confidence intervals (CIs).
Sensitivity, specificity, positive and negative predictive val-
ues, and predictive accuracy of event-free prediction were
also evaluated. Differences in arrhythmic event-free rates
were determined using the Kaplan-Meier method and the
log-rank test. A value for p , 0.05 was considered statisti-
cally significant.
RESULTS
Patient characteristics and arrhythmic events. The dura-
tion of follow-up was 13 6 6 months (range: 3 to 23
months). The clinical characteristics of 102 patients after
acute MI are summarized in Table 1. No patients had
congestive heart failure that was refractory to medical
therapy or other organic heart disease during the follow-up
period. In this study population, most of the patients
received coronary revascularization procedures during the
acute phase of MI. Furthermore, nine patients (9%) had no
abnormal Q waves on standard 12-lead ECG at the time of
noninvasive testing.
During the follow-up period, 15 patients (15%) had
documented symptomatic, spontaneous ventricular arrhyth-
mias as shown in Figure 1. The arrhythmic events occurred
within six months after acute MI (mean: 2.5 6 1.9 months).
Characteristics of documented ventricular arrhythmias and
results of three indices in the 15 patients are shown in Table
2. Patient number in Table 2 corresponds to the number in
Figure 1. In this study, three patients (Patients 3, 4, 11)
with the events that occurred at days 14, 17, and 24,
respectively, after MI during their hospitalization were
included among patients who experienced the events be-
cause these days were remote from the onset of acute MI.
Sustained ventricular arrhythmias were terminated by defi-
brillation shocks in 2 patients, cardioversion in 11 patients,
Figure 1. Individual ECG tracings in 15 patients revealing the
occurrence of spontaneous, sustained ventricular arrhythmias.
These tracings were recorded by any standard 12-lead ECG
(patients 1–3, 5, 7–13, 15), conventional monitor ECG recorders
(patients 4, 6), or 24-h Holter monitoring (patient 14). II indicates
lead II in standard 12-lead ECGs, and CC5 indicates lead CC5 in
Holter monitoring. Patient number corresponds to the number in
Table 2.
Table 1. Clinical Characteristics of 102 Patients With and
Without Arrhythmic Events After Acute MI
Variable
Arrhythmic
Event
(n 5 15)
No
Arrhythmic
Event
(n 5 87)
p
Value
Age (mean 6 SD), yr 61 6 6 59 6 10 NS
Gender, male 13 72 NS
Heart rate at rest,
beats/min
66 6 7 72 6 14 NS
Site of infarction
Anterior wall 11 39 0.04
Inferior wall 4 31 NS
Aneurysm 4 7 0.03
No abnormal Q waves 0 9 NS
Coronary intervention 14 81 NS
Coronary bypass surgery 2 10 NS
Beta-blocker use 5 27 NS
History of
Myocardial infarction 3 4 NS
Hypertension 9 36 NS
Diabetes mellitus 4 27 NS
T-wave alternans 14 (93%) 36 (41%) 0.0002
Late potential 8 (53%) 13 (15%) 0.002
Ejection fraction (,40%) 9 (60%) 19 (22%) 0.004
Arrhythmic events include symptomatic, sustained ventricular tachycardia and ven-
tricular fibrillation.
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an intravenous administration of procainamide in 1 patient,
and spontaneously in 1 patient. Eight of 12 patients
followed as outpatients were hospitalized to treat the ar-
rhythmias because the arrhythmias were associated with
severe symptoms, such as syncope, dizziness, and palpita-
tions with hypotension. The remaining four patients were
also not hospitalized because in three patients (Patients 1, 8,
10), the arrhythmias were hemodynamically stable and the
symptoms were not so severe, and in one patient (Patient
14), the arrhythmia was recorded on 24-h Holter monitor-
ing (Fig. 2). A rapid polymorphic sustained ventricular
tachycardia was documented in a patient (Patient 13) who
received resuscitation. This event was not associated with
acute MI because of the confirmation by coronary angiog-
raphy after the event.
Although two patients (Patients 4 and 6) had ventricular
fibrillation, both patients were rescued by resuscitations
with several defibrillation shocks. Three patients with either
rapid polymorphic sustained ventricular tachycardia or ven-
tricular fibrillation and one patient with monomorphic
sustained ventricular tachycardia that was refractory to
antiarrhythmic drugs received subsequent implantation of a
Figure 2. Holter recording revealing spontaneous onset and termination of sustained ventricular tachycardia documented in Patient 14.
NASA and CC5 indicate lead NASA and CC5, respectively, in Holter monitoring.
Table 2. Characteristics of Documented Ventricular Arrhythmias and Results of Three Indices in 15 Patients
Patient
No. Age/Gender Symptom Type of Arrhythmia
Tachycardia
Rate
(beats/min)
Duration
(min)
Mode of
Termination TWA LP EF
1 56/M Palpitation Sustained monomorphic VT 152 90 Cardioversion 1 1 36
2 51/M Dizziness Sustained monomorphic VT 210 60 Cardioversion 1 2 59
3 66/M Palpitation with
hypotension
Sustained monomorphic VT 182 10 Cardioversion 1 1 34
4 59/M Syncope VF .300 5 Defibrillation
shocks
1 1 39
5 56/M Palpitation with
hypotension
Sustained monomorphic VT 140 100 Procainamide 1 2 24
6 74/M Syncope VF .300 30 Defibrillation
shocks
1 1 36
7 71/M Dizziness Sustained monomorphic VT 190 90 Cardioversion 1 2 37
8 69/M Palpitation Sustained monomorphic VT 156 100 Cardioversion 2 2 65
9 73/M Palpitation with
hypotension
Sustained monomorphic VT 204 60 Cardioversion 1 1 38
10 45/M Palpitation Sustained monomorphic VT 166 120 Cardioversion 1 2 53
11 67/M Palpitation with
hypotension
Sustained monomorphic VT 192 20 Cardioversion 1 2 48
12 57/M Presyncope Sustained monomorphic VT 210 40 Cardioversion 1 1 46
13 53/M Presyncope Sustained polymorphic VT 250 30 Cardioversion 1 1 58
14 69/M Palpitation Sustained monomorphic VT 190 4 Spontaneously 1 1 35
15 43/M Palpitation with
hypotension
Sustained monomorphic VT 168 90 Cardioversion 1 2 33
TWA 5 T-wave alternans; LP, late potentials; EF 5 left ventricular ejection fraction; VT 5 ventricular tachycardia; VF 5 ventricular fibrillation.
Patient number corresponds to the number in Figure 1.
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cardiac defibrillator. The remaining 11 patients were treated
with amiodarone or class I antiarrhythmic drugs. In patients
with arrhythmic events, the incidences of an anterior wall
infarction and left ventricular aneurysm were higher than in
patients without arrhythmic events (Table 1). With respect
to other clinical features, no significant differences existed
between patients with and without arrhythmic events.
Presence of abnormal noninvasive markers. T-WAVE AL-
TERNANS. Of the 102 patients, 50 patients (49%) had
evidence of TWA. Of the patients with TWA, 34 (68%)
did not have LP, and 27 patients (54%) had a normal EF.
In patients with TWA, eight had TWA at rest with a mean
heart rate of 94 6 8 beats/min. The remaining 42 patients
developed TWA as their heart rate increased during exercise
stress testing (Fig. 3). During the TWA determination test,
none of the patients complained of chest pain; none had
significant ST-segment depression. The maximum Valt for
patients with TWA was 4.9 6 4.8 mV, and the maximum
Ralt was 47 6 70. The incidence of TWA in patients with
arrhythmic events was significantly higher (p 5 0.0002)
than that in patients without arrhythmic events (Table 1).
LATE POTENTIALS. Twenty-one of the 102 patients (21%)
had LP. Of the patients with LP, five (24%) did not have
TWA and three patients (14%) had a normal EF. In
patients with arrhythmic events, the incidence of LP was
significantly higher (p 5 0.002) than in patients without
arrhythmic events. An f-QRS .114 ms was observed in 23
patients, a RMS40 ,20 mV was noted in 20 patients, and an
LAS40 .38 ms was present in 21 patients.
ABNORMAL EF. The mean EF for all 102 patients was 49 6
9%. The EF was ,40% in 28 patients (27%) and $40% in
74 patients (73%). Eleven patients had evidence of a left
ventricular aneurysm. The percentage of patients with an
abnormal EF (,40%) was significantly higher (p 5 0.004)
in patients with an arrhythmic event than in patients
without an arrhythmic event.
TWA, late potentials and EF as predictors of arrhythmic
events. The predictive values of TWA, LP, and EF alone,
and the combination of the three markers in predicting
arrhythmic events, are shown in Table 3. There were 16
patients with both TWA and LP, 23 patients with TWA
and an abnormal EF, 18 patients with LP and an abnormal
EF, and 14 patients with all three markers. Using a single
marker, TWA had the highest sensitivity (93%) and the
highest negative predictive value (98%), although the spec-
ificity (59%) and positive predictive value (28%) were lower
than for LP or EF. Although LP had a higher specificity
(85%) than TWA, the other predictive values were low,
especially the positive predictive value. An abnormal EF
also had a low positive predictive value. When TWA and
LP were combined, the highest positive predictive value
(50%) and the highest predictive accuracy (85%) were
achieved. This was associated with a sensitivity of 53%, a
specificity of 91%, and a negative predictive value of 92%.
The other combinations of two markers (TWA and EF, or
LP and EF) were inferior to the combination of TWA and
LP. If all three markers were combined, the positive
predictive value was lower than the combination of TWA
and LP.
Univariate Cox regression analyses were performed to
identify independent predictors of arrhythmic events (Table
3). In a single use, all three markers were statistically
significant. Although TWA alone had the highest relative
hazard (16.8 [95% CI 2.2 to 127.8]) among predictors, the
Figure 3. Representative data for a patient with a typical microvolt
alternans of the T wave during exercise testing. Alternans analysis
for leads VM, X, Y, Z, and V4 is shown. The dark shaded areas
for each lead indicate regions for which the Valt has a Ralt $3 SD
above the level of noise. Dark shaded areas, which also have %Bad,
RPM, Resp and HR Delta indices in the acceptable range, are
indicated by a black line along the time axis. In this representative
patient, the Valt is 8.8 mV and the Ralt is 759 for lead Z. The
alternans increased as the heart rate increased. HR, heart rate
trend; %Bad, percentage of beats more than 10% premature;
Noise, mean noise in lead VM; eVM, eX, eY, eZ, eV4, enhanced
VM, X, Y, Z, and V4 leads; RPM, bicycle ergometer pedaling rate
during exercise; Resp, respiratory frequency (0.25 cycles/beat); HR
Delta, the difference between the highest and lowest instantaneous
heart rates for a 128-consecutive beat interval; RR Alternans, the
amplitude of RR interval alternans.
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statistical significance (p 5 0.006) was inferior to the
combined use of TWA and LP (p , 0.0001). To test
explicitly the statistical significance of the combination of
TWA and LP in predicting arrhythmic events, we specifi-
cally examined a multivariate Cox regression analysis involv-
ing TWA alone and the combination of TWA and other
markers (Table 4). The combination of TWA and LP was
the most significant (p 5 0.001) predictor, providing the
highest relative hazard (19.9 [95% CI 3.2–125.3]). Figure 4
depicts the event-free curves for TWA, LP and the com-
bination of both tests during a mean follow-up period of 13
months. The combination of TWA and LP was a most
significant predictor at this time point (p , 0.0001).
DISCUSSION
TWA and arrhythmias. Previously, “visual” TWA, which
consists of beat-to-beat changes in the morphology of the T
wave on the surface ECG, was reported to be associated
with the development of ventricular arrhythmias in experi-
mental and clinical settings, including acute ischemia (16–
19), Prinzmetal angina (20,21), long QT syndrome (22,23),
and metabolic and electrolyte abnormalities (24). Recently,
a spectral analysis technique, incorporating noise reduction
signal processing, allows the detection of microvolt electrical
alternans of the T wave (“microscopic” TWA) (7,12). In
addition, it has been proposed that “microscopic” TWA can
be measured during bicycle exercise stress testing (8,9). The
presence of “microscopic” TWA has been reported to be
associated with an increased risk of ventricular arrhythmias
in several clinical settings (8,14,25–27). No studies have
demonstrated the predictive significance of TWA with
respect to arrhythmic events in the setting of acute MI. The
present prospective study suggests that TWA is an inde-
pendent predictor of arrhythmic events. Because both the
sensitivity and negative predictive value of TWA were very
high (93% and 98%, respectively), TWA could be utilized in
the primary screening of patients for serious ventricular
arrhythmias after acute MI. However, the positive predic-
tive value was lower than LP or an abnormal EF.
Comparison with previous studies. The LP are low-
amplitude signals in the terminal portion of the QRS
complex assessed by signal-averaged ECG (28,29). The
prognostic value of LP in predicting sustained ventricular
tachycardia or sudden death following acute MI has been
evaluated in several studies (1–3,28–30). In these studies,
the signal-averaged ECG was performed at a time similar to
that in the present study, less than one month after
infarction. The LP were found in 12% to 44% of the
patients studied. Patients with definite LP had a 4.3% to
14.7% incidence of arrhythmic events during the follow-up
period (10 to 12 months). In the present study, LP were
noted in 21% of patients, and the arrhythmic events were
documented in 15% of those patients during a mean
follow-up of 13 months. The incidence of definite LP was
comparable to those in previous reports. However, the
incidence of arrhythmic events in the present study group
was slightly higher.
In several previous reports (1,3), a higher proportion of
patients without arrhythmic events received antiarrhythmic
drugs or beta-blockers. In the present study, although
beta-blockers were occasionally used (no significant differ-
ence in beta-blocker use between patients with and without
arrhythmic events), antiarrhythmic drugs were not admin-
istered during the follow-up period. Moreover, hemody-
namically stable and sustained ventricular tachycardias were
included in arrhythmic events because the study end point
was the documentation of ventricular arrhythmias. These
may influence a higher incidence of arrhythmic events.
Recently, Estes at al. (8) have shown that TWA is a
predictor of arrhythmic vulnerability in a small patient
population (n 5 27) that included a high proportion of
Table 3. Predictive Values and Univariate Cox Regression Analyses Associating Three Indices Used Alone and in Combination With
Arrhythmic Events
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
PA
(%) RH (95% CI) p Value
TWA 93 59 28 98 64 16.8 (2.2–127.8) 0.006
LP 53 85 38 91 80 5.7 (2.1–15.7) 0.0008
EF 60 78 32 92 75 4.7 (1.7–13.2) 0.004
TWA and LP 53 91 50 92 85 8.6 (3.1–23.9) ,0.0001
TWA and EF 60 84 39 92 80 6.3 (2.3–17.8) 0.0005
LP and EF 40 86 33 89 79 3.8 (1.4–10.8) 0.01
TWA and LP and EF 40 91 43 90 83 5.5 (2.0–15.5) 0.001
TWA 5 T-wave alternans; LP 5 late potentials; EF 5 ejection fraction; PPV 5 positive predictive value; NPV 5 negative predictive value; PA 5 predictive accuracy; RH 5
relative hazard; CI 5 confidence interval.
Table 4. Result of a Multivariate Cox Regression Analysis
Relative Hazard
(95% CI) p Value
TWA 6.5 (0.7–62.2) 0.11
TWA and LP 19.9 (3.2–125.3) 0.001
TWA and EF 3.1 (0.6–15.3) 0.17
TWA and LP and EF 0.1 (0.01–0.8) 0.03
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patients with syncope, while LP is not a predictor of
arrhythmic events. More recently, Hohnloser et al. (14)
have also found that in recipients of an implantable cardio-
verter defibrillator (75% of the study group had coronary
artery disease), determinate TWA (n 5 62) is a most
predicting marker for recurrent ventricular arrhythmias,
while LP (n 5 85) is not. In our study of patients with acute
MI (n 5 102), both TWA and LP were significant
predictors of first onset of ventricular arrhythmias.
The EF, determined by echocardiography, radionuclide
ventriculography or ventriculography, is commonly used in
clinical practice. A number of studies have shown that an
EF ,40% predicts serious arrhythmic events and sudden
cardiac death in patients after infarction (1–3). Although an
EF ,40% was an independent predictor of future arrhyth-
mic events in the present study, the positive predictive value
was lower than for LP, which is in keeping with several
previous studies (1–3,28–30).
Predictive significance of combined noninvasive indices.
The single use of either TWA, LP, or EF has limited
usefulness in predicting arrhythmic events after acute MI in
this study. Specifically, the positive predictive value is 28%
to 38%, although the negative predictive value is very high
(91% to 98%). Previous prospective studies have assessed
the combination of several noninvasive predictors, including
LP and EF, to identify patients at risk for arrhythmic events
and sudden cardiac death. Kuchar et al. (2) and Gomes et al.
(3) have found that in patients with LP and a reduced EF
(,40%), the risk of arrhythmic events (i.e., the positive
predictive value) was 34% to 36%. In the present study, the
combination of TWA and LP had the highest positive
predictive value (50%) with the highest predictive accuracy
(85%), providing the most significant value in both univar-
iate and multivariate analyses. The combination of both
markers therefore could be a useful noninvasive index
reflecting abnormalities of both ventricular depolarization
and repolarization. When all three markers were combined,
the positive predictive value was no better than for the
combination of TWA and LP. This may be due to the fact
that we excluded patients with a severely reduced EF
(,20%). This exclusion criterion was necessary to ensure
the performance of a successful TWA determination test
during exercise.
Study limitations. In previous prospective studies (1–3),
the use of antiarrhythmic drug therapy was not controlled in
the study group. In the present study, antiarrhythmic drugs
were not administered during the follow-up period. How-
ever, our study population was limited because of testing
constraints. First, patients with frequent extrasystoles ($10
beats/min) and a high degree of R-R interval variability
(,85% or .115% of qualified sinus beats) were excluded
from the study. Previous reports have suggested that the
detection of ventricular ectopy by Holter monitoring and
abnormal heart rate variability were both predictors of
Figure 4. Kaplan-Meier actuarial curves for arrhythmic event-free rates based on positive or negative for T-wave alternans (TWA) (A),
late potentials (B), and the combination of the two noninvasive tests (C) following acute myocardial infarction. The combination of TWA
positive and LP positive had poorer event-free (p , 0.0001) than the other.
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arrhythmic events (4,5). Therefore, our results may not be
applicable to patients with significant accounts of ventricular
ectopy or abnormal heart rate variability. However, TWA,
LP, and an abnormal EF seem to be important prognostic
factors in identifying patients with the substrate for reen-
trant ventricular arrhythmias. Second, we excluded patients
with a very low EF (,20%), who are at most concern for
risk stratification. Our data may not be applied to patients
with severe congestive heart failure.
Clinical implications. Although previous reports have
suggested that programmed ventricular stimulation can
identify patients at high risk for ventricular arrhythmias
(30), noninvasive measurements are more desirable as a
screening test in a large number of patients with acute MI.
This study shows that TWA is a useful marker to identify
such patients because the sensitivity and the negative pre-
dictive value were very high. Second, the combination of
TWA and LP can be used to identify patients at high risk
for the development of ventricular arrhythmias following
acute MI.
Reprint requests and correspondence: Dr. Takanori Ikeda, Staff
Cardiologist, Third Department of Internal Medicine, Ohashi
Hospital, Toho University School of Medicine, 2-17-6 Ohashi,
Meguro, Tokyo 153-8515, Japan. E-mail: iket@oha.toho-u.ac.jp.
REFERENCES
1. El-Sherif N, Denes P, Katz R, et al. for the Cardiac Arrhythmia
Suppression Trial/Signal-Averaged Electrocardiogram (CAST/
SAECG) substudy investigators. Definition of the best prediction
criteria of the time domain signal-averaged electrocardiogram for
serious arrhythmic events in the postinfarction period. J Am Coll
Cardiol 1995;25:908–14.
2. Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious
arrhythmic events after myocardial infarction: signal-averaged electro-
cardiogram, Holter monitoring and radionuclide ventriculography.
J Am Coll Cardiol 1987;9:531–8.
3. Gomes JA, Winters SL, Stewart D, et al. A new noninvasive index to
predict sustained ventricular tachycardia and sudden death in the first
year after myocardial infarction: based on dignal-averaged electrocar-
diogram, radionuclide ejection fraction and Holter monitoring. J Am
Coll Cardiol 1987;10:349–57.
4. Winkle RA. Ambulatory electrocardiology and the diagnosis, evalua-
tion, and treatment of chronic ventricular arrhythmias. Prog Cardio-
vasc Dis 1980;23:99–128.
5. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate
variability and its association with increased mortality after acute
myocardial infarction. Am J Cardiol 1987;59:256–62.
6. Barr CS, Naas A, Freeman M, et al. QT dispersion and sudden
unexpected death in chronic heart failure. Lancet 1994;343:327–9.
7. Rosenbaum DS, Jackson LE, Smith JM, et al. Electrical alternans and
vulnerability to ventricular arrhythmias. N Engl J Med 1994;330:235–
41.
8. Estes NAM III, Zipes DP, El-Sherif N, et al. Electrical alternans
during rest and exercise as predictors of vulnerability to ventricular
arrhythmias. Am J Cardiol 1997;80:1314–8.
9. Hohnloser SH, Klingenheben T, Zabel M, et al. T-wave alternans
during exercise and atrial pacing in humans. J Cardiovasc Electro-
physiol 1997;8:987–93.
10. Tsunoda T, Nakamura M, Wakatsuki T, et al. The pattern of
alternation in flow velocity in the recanalized artery is related to left
ventricular recovery in patients with acute infarction and successful
direct balloon angioplasty. J Am Coll Cardiol 1998;32:338–44.
11. Gomes JA, Winters SL, Steward D, et al. Optimal bandpass filters for
time-domain analysis of the signal-averaged electrocardiogram. Am J
Cardiol 1987;60:1290–8.
12. Rosenbaum DS, Albrecht P, Cohen RJ. Predicting sudden cardiac
death from T-wave alternans of the surface electrocardiogram: promise
and pitfalls. J Cardiovasc Electrophysiol 1996;7:1095–111.
13. Smith JM, Clancy EA, Valeri CR, Ruskin JN, Cohen RJ. Electrical
alternans and clinical electrical instability. Circulation 1988;77:110–
21.
14. Hohnloser SH, Klingenheben T, Li Y-G, et al. T-wave alternans as a
predictor of recurrent ventricular tachyarrhythmias in ICD recipients:
prospective comparison with conventional risk markers. J Cardiovasc
Electrophysiol 1998;9:1258–69.
15. Murda’h MA, Mckenna WJ, Camm AJ. Repolarization alternans:
techniques, mechanisms, and cardiac vulnerability. Pacing Clin Elec-
trophysiol 1997;20:2641–57.
16. Puletti M, Curione M, Righetti G, Jacobellis G. Alternans of the ST
segment and T wave in acute myocardial infarction. J Electrocardiol
1980;13:297–300.
17. Verrier RL, Nearing BD. Electrophysiologic basis for T-wave alter-
nans as an index of vulnerability to ventricular fibrillation. J Cardiovasc
Electrophysiol 1994;5:445–61.
18. Nearing BD, Oesterle SN, Verrier RL. Quantification of ischemia-
induced vulnerability by precordial T-wave alternans analysis in dog
and human. Cardiovasc Res 1994;28:1440–9.
19. Joyal M, Feldman RL, Pepine CJ. ST-segment alternans during
percutaneous transluminal coronary angioplasty. Am J Cardiol 1984;
54:915–6.
20. Rozanski JJ, Kleinfeld M. Alternans of the ST segment and T wave:
a sign of electrical instability in Prinzmetal’s angina. Pacing Clin
Electrophysiol 1982;5:359–65.
21. Turitto G, El-Sherif N. Alternans of the ST segment in variant
angina. Chest 1988;93:587–91.
22. Zereba W, Moss AJ, Le Cessie S, Hall WJ. T-wave alternans in
idiopathic long QT syndrome. J Am Coll Cardiol 1994;23:1541–6.
23. Platt SB, Vijgen JM, Albrecht P, et al. Occult T-wave alternans in
long QT syndrome. J Cardiovasc Electrophysiol 1996;7:144–8.
24. Reddy CVR, Kiok JP, Khan RG, El-Sherif N. Repolarization alter-
nans associated with alcoholism and hypomagnesemia. Am J Cardiol
1984;53:390–1.
25. Momiyama Y, Hartikainen J, Nagayoshi H, et al. Exercise-induced
T-wave alternans as a marker of high risk in patients with hypertrophic
cardiomyopathy. Jpn Circ J 1997;61:650–6.
26. Adachi K, Ohnishi Y, Shima T. Determinant microvolt-level T-wave
alternans in patients with dilated cardiomyopathy. J Am Coll Cardiol
1999;34:374–80.
27. Klingenheben T, Cohen RJ, Peetermans JA, Hohnloser SH. Predic-
tive value of T-wave alternans in patients with congestive heart failure
(abstr). Circulation 1998;98 Suppl:I-864.
28. Simson MB. Use of signals in the terminal QRS complex to identify
patients with ventricular tachycardia after myocardial infarction. Cir-
culation 1981;64:235–42.
29. Rozanski JJ, Mortara D, Myeburg RJ, Castellanos A. Body surface
detection of delayed depolarizations in patients with recurrent ventric-
ular tachycardia and left ventricular aneurysm. Circulation 1981;63:
1172–8.
30. Denniss AR, Richards DA, Cody DV, et al. Prognostic significance of
ventricular tachycardia and fibrillation induced at programmed stim-
ulation and delayed potentials detected on the signal-averaged elec-
trocardiograms of survivors of acute myocardial infarction. Circulation
1986;74:731–45.
730 Ikeda et al. JACC Vol. 35, No. 3, 2000
Combination of TWA and LP in Predicting Arrhythmic Events March 1, 2000:722–30
